Financials

News Ideas Technicals Forecast

VPH fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Valeo Pharma, Inc. engages in the acquisition and in-licensing of branded pharmaceutical and hospital specialty products for sale. Its product portfolio includes respiratory/allergy, specialty products, ophthalmology, neurology, and oncology. The company was founded by Steven Saviuk on March 27, 2003 and is headquartered in Kirkland, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

VPH does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company